Elekta AB (publ) (EKTAY)
USD 5.45
(-0.55%)
USD 5.45
(-0.55%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 31.41 Billion SEK | 6.1% |
| 2023 | 29.6 Billion SEK | 12.57% |
| 2022 | 26.3 Billion SEK | 5.87% |
| 2021 | 24.84 Billion SEK | -12.55% |
| 2020 | 28.41 Billion SEK | 18.06% |
| 2019 | 24.06 Billion SEK | 7.16% |
| 2018 | 22.45 Billion SEK | 7.19% |
| 2017 | 20.95 Billion SEK | 7.76% |
| 2016 | 19.44 Billion SEK | -8.23% |
| 2015 | 21.18 Billion SEK | 18.4% |
| 2014 | 17.89 Billion SEK | 9.72% |
| 2013 | 16.3 Billion SEK | 7.04% |
| 2012 | 15.23 Billion SEK | 70.0% |
| 2011 | 8.96 Billion SEK | 5.25% |
| 2010 | 8.51 Billion SEK | 7.09% |
| 2009 | 7.95 Billion SEK | 25.77% |
| 2008 | 6.32 Billion SEK | 18.04% |
| 2007 | 5.35 Billion SEK | 1.36% |
| 2006 | 5.28 Billion SEK | 17.45% |
| 2005 | 4.49 Billion SEK | 46.26% |
| 2004 | 3.07 Billion SEK | 3.85% |
| 2003 | 2.96 Billion SEK | 16.8% |
| 2002 | 2.53 Billion SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 31.61 Billion SEK | 2.57% |
| 2024 Q3 | 30.73 Billion SEK | -2.79% |
| 2024 Q4 | 31.41 Billion SEK | 2.22% |
| 2024 FY | 31.41 Billion SEK | 6.1% |
| 2024 Q1 | 30.82 Billion SEK | 4.1% |
| 2023 Q3 | 27.97 Billion SEK | 2.74% |
| 2023 Q1 | 26.32 Billion SEK | 0.07% |
| 2023 Q4 | 29.6 Billion SEK | 5.85% |
| 2023 FY | 29.6 Billion SEK | 12.57% |
| 2023 Q2 | 27.22 Billion SEK | 3.43% |
| 2022 Q3 | 27.57 Billion SEK | 15.66% |
| 2022 Q1 | 24.2 Billion SEK | -2.59% |
| 2022 Q2 | 23.84 Billion SEK | -1.48% |
| 2022 FY | 26.3 Billion SEK | 5.87% |
| 2022 Q4 | 26.3 Billion SEK | -4.62% |
| 2021 FY | 24.84 Billion SEK | -12.55% |
| 2021 Q4 | 24.84 Billion SEK | -2.43% |
| 2021 Q3 | 25.46 Billion SEK | -0.13% |
| 2021 Q1 | 26.79 Billion SEK | -5.68% |
| 2021 Q2 | 25.49 Billion SEK | -4.85% |
| 2020 FY | 28.41 Billion SEK | 18.06% |
| 2020 Q3 | 25.23 Billion SEK | -0.02% |
| 2020 Q4 | 28.41 Billion SEK | 12.59% |
| 2020 Q2 | 25.23 Billion SEK | 1.54% |
| 2020 Q1 | 24.85 Billion SEK | 3.29% |
| 2019 Q1 | 21.92 Billion SEK | -2.39% |
| 2019 FY | 24.06 Billion SEK | 7.16% |
| 2019 Q4 | 24.06 Billion SEK | 6.08% |
| 2019 Q2 | 22.64 Billion SEK | 3.3% |
| 2019 Q3 | 22.68 Billion SEK | 0.18% |
| 2018 Q1 | 19.65 Billion SEK | -6.16% |
| 2018 Q2 | 20.15 Billion SEK | 2.51% |
| 2018 Q3 | 20.61 Billion SEK | 2.31% |
| 2018 FY | 22.45 Billion SEK | 7.19% |
| 2018 Q4 | 22.45 Billion SEK | 8.92% |
| 2017 Q1 | 19.5 Billion SEK | 0.3% |
| 2017 Q4 | 20.95 Billion SEK | 6.41% |
| 2017 Q3 | 19.68 Billion SEK | -1.89% |
| 2017 Q2 | 20.06 Billion SEK | 2.91% |
| 2017 FY | 20.95 Billion SEK | 7.76% |
| 2016 Q4 | 19.44 Billion SEK | -0.7% |
| 2016 Q1 | 21.31 Billion SEK | 0.62% |
| 2016 FY | 19.44 Billion SEK | -8.23% |
| 2016 Q2 | 19.78 Billion SEK | -7.19% |
| 2016 Q3 | 19.57 Billion SEK | -1.03% |
| 2015 Q3 | 19 Billion SEK | 8.7% |
| 2015 Q4 | 21.18 Billion SEK | 11.49% |
| 2015 Q2 | 17.48 Billion SEK | -0.32% |
| 2015 Q1 | 17.53 Billion SEK | -1.98% |
| 2015 FY | 21.18 Billion SEK | 18.4% |
| 2014 Q3 | 15.87 Billion SEK | 2.99% |
| 2014 Q4 | 17.89 Billion SEK | 12.68% |
| 2014 Q2 | 15.41 Billion SEK | -2.06% |
| 2014 Q1 | 15.74 Billion SEK | -3.47% |
| 2014 FY | 17.89 Billion SEK | 9.72% |
| 2013 Q4 | 16.3 Billion SEK | 10.85% |
| 2013 FY | 16.3 Billion SEK | 7.04% |
| 2013 Q3 | 14.71 Billion SEK | 0.32% |
| 2013 Q2 | 14.66 Billion SEK | 0.03% |
| 2013 Q1 | 14.66 Billion SEK | -3.77% |
| 2012 Q4 | 15.23 Billion SEK | 15.44% |
| 2012 FY | 15.23 Billion SEK | 70.0% |
| 2012 Q1 | 10.11 Billion SEK | 12.82% |
| 2012 Q2 | 11.96 Billion SEK | 18.33% |
| 2012 Q3 | 13.19 Billion SEK | 10.31% |
| 2011 Q4 | 8.96 Billion SEK | 3.91% |
| 2011 Q1 | 8.43 Billion SEK | -0.92% |
| 2011 Q2 | 8.17 Billion SEK | -3.11% |
| 2011 Q3 | 8.62 Billion SEK | 5.5% |
| 2011 FY | 8.96 Billion SEK | 5.25% |
| 2010 FY | 8.51 Billion SEK | 7.09% |
| 2010 Q4 | 8.51 Billion SEK | 0.0% |
| 2009 FY | 7.95 Billion SEK | 25.77% |
| 2008 FY | 6.32 Billion SEK | 18.04% |
| 2007 FY | 5.35 Billion SEK | 1.36% |
| 2006 FY | 5.28 Billion SEK | 17.45% |
| 2005 FY | 4.49 Billion SEK | 46.26% |
| 2004 FY | 3.07 Billion SEK | 3.85% |
| 2003 FY | 2.96 Billion SEK | 16.8% |
| 2002 FY | 2.53 Billion SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | -1708930.173% |
| Ansell Limited | 3.23 Billion USD | -870.576% |
| Ansell Limited | 3.24 Billion USD | -868.76% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | -6324.076% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | -10458280.221% |
| Psykey, Inc. | 1.72 Million USD | -1818455.484% |
| ConvaTec Group Plc | 3.7 Billion USD | -747.064% |
| ConvaTec Group Plc | 3.71 Billion USD | -745.868% |
| Encision Inc. | 3.81 Million USD | -824233.275% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | -4818724.295% |
| LifePoint, Inc. | 8.8 Million USD | -356494.281% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | -196772.65% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | -3509732.402% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | -572185.551% |
| Reflect Scientific, Inc. | 2.66 Million USD | -1176900.438% |
| SmileDirectClub, Inc. | 597.06 Million USD | -5161.254% |
| Sector 10, Inc. | 1000.00 USD | -3141299900.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | -561.854% |
| SheerVision, Inc. | 837.56 Thousand USD | -3750414.885% |
| United Health Products, Inc. | 284.64 Thousand USD | -11035829.217% |
| Vasamed, Inc. | 1.6 Million USD | -1962914.367% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -14075527.428% |
| Yubo International Biotech Limited | 2.34 Million USD | -1337448.131% |